scholarly journals Implantable Cardiac Device Procedures in Older Patients

2010 ◽  
Vol 170 (7) ◽  
Author(s):  
Jason P. Swindle ◽  
Michael W. Rich ◽  
Patrick McCann ◽  
Thomas E. Burroughs ◽  
Paul J. Hauptman
Keyword(s):  
Older Patients ◽  
Cardiac Device ◽  
Implantable Cardiac Device

Abstract 23: Detection of Atrial Fibrillation by Implantable Cardiac Monitoring After Acute Central Retinal Artery Occlusion

Stroke ◽  
2020 ◽  
Vol 51 (Suppl_1) ◽  
Author(s):  
Brian C Mac Grory ◽  
Paul D Ziegler ◽  
Sean Landman ◽  
Amador Delamerced ◽  
Anusha Boyanpally ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Ischemic Stroke ◽  
Central Retinal Artery Occlusion ◽  
Retinal Artery Occlusion ◽  
Artery Occlusion ◽  
Central Retinal Artery ◽  
Cardiac Device ◽  
History Of ◽  
Implantable Cardiac Device ◽  
Retinal Artery

Introduction: Central retinal artery occlusion (CRAO) is a form of ischemic stroke and necessitates a comprehensive workup, including for cardioembolic sources such as atrial fibrillation (AF). However, the incidence of new AF diagnosed after CRAO is unknown. We aimed to examine the incidence of new, cardiac device-detected AF after CRAO in a large population-based cohort. Methods: Using patient-level data from the Optum® de-identified EHR dataset (2007-2017) linked with Medtronic implantable cardiac device data, we identified patients that had a diagnosis-code corresponding to CRAO and no known history of AF, and who also had either a device in-situ at the time of CRAO or implanted ≤1 year post-CRAO with continuous AF monitoring data available. AF incidence was defined as ≥2 minutes of device-detected AF in a day. Results: Of 467,167 patients screened, 246/433 (56.8%) with CRAO had no history of AF, of whom 39 had an eligible implantable cardiac device (mean age 66.7±14.8, 41.0% female). Prevalence of vascular risk factors was high (hypertension, 71.8%; hyperlipidemia, 61.5%; coronary artery disease, 46.2%). Within 3 months, 7.7% of these patients (n=3) had device-detected AF. At 36 months, 33.3% of patients (n=13). The maximum daily AF burden post CRAO ranged from 2 minutes to 24 hours with a mean of 390±530 minutes. Of the patients with device-detected AF, 9 were found by an implantable cardiac monitor and 4 by pacemaker or defibrillator. Discussion: The rate of long-term AF detection after CRAO was high in patients with implanted cardiac devices, and appears comparable with rates seen after cryptogenic ischemic stroke and in other high-risk populations. Our findings warrant future prospective studies not limited by selection bias.

scholarly journals Erratum to: Providing Patients with Implantable Cardiac Device Data through a Personal Health Record: A Qualitative Study

2017 ◽  
Vol 08 (04) ◽  
pp. e1-e1
Author(s):  
Carly Daley ◽  
Elizabeth Chen ◽  
Amelia Roebuck ◽  
Romisa Ghahari ◽  
Areej Sami ◽  
...  
Keyword(s):  
Qualitative Study ◽  
Personal Health Record ◽  
Personal Health ◽  
Health Record ◽  
Cardiac Device ◽  
Implantable Cardiac Device

A Pilot Study of Implantable Cardiac Device Interrogation by Emergency Department Personnel

2014 ◽  
Vol 13 (1) ◽  
pp. 6-8 ◽  
Author(s):  
James F. Neuenschwander ◽  
Brian C. Hiestand ◽  
W. Frank Peacock ◽  
John M. Billings ◽  
Cole Sondrup ◽  
...  
Keyword(s):  
Emergency Department ◽  
Pilot Study ◽  
Cardiac Device ◽  
Implantable Cardiac Device

scholarly journals 76 * Implantable cardiac device extraction in a non-surgical centre is safe and effective

EP Europace ◽  
2014 ◽  
Vol 16 (suppl 3) ◽  
pp. iii29-iii29
Author(s):  
R. W. Bowers ◽  
S. Iacovides ◽  
W. M. S. Foster ◽  
R. N. Balasubramaniam ◽  
S. M. Sopher ◽  
...  
Keyword(s):  
Cardiac Device ◽  
Implantable Cardiac Device ◽  
Device Extraction

The Role of Swab and Tissue Culture in the Diagnosis of Implantable Cardiac Device Infection

2005 ◽  
Vol 28 (12) ◽  
pp. 1276-1281 ◽  
Author(s):  
JIMMY DY CHUA ◽  
AHMAD ABDUL-KARIM ◽  
STEVEN MAWHORTER ◽  
GARY W. PROCOP ◽  
PATRICK TCHOU ◽  
...  
Keyword(s):  
Tissue Culture ◽  
Cardiac Device ◽  
Device Infection ◽  
Implantable Cardiac Device ◽  
Cardiac Device Infection

Percutaneous aspiration of vegetation from tricuspid valve infective endocarditis

2020 ◽  
Keyword(s):  
Infective Endocarditis ◽  
Tricuspid Valve ◽  
Heart Surgery ◽  
Open Heart Surgery ◽  
Percutaneous Aspiration ◽  
Cardiac Device ◽  
Percutaneous Approach ◽  
Vegetation Removal ◽  
Real Time Visualization ◽  
Implantable Cardiac Device

We present a novel minimally invasive percutaneous approach for the surgical treatment of tricuspid valve infective endocarditis. In this case, the patient presented with a malfunctioning implantable cardiac device, right ventricle implantable cardiac device lead infection, and infective endocarditis of the tricuspid valve. The infective endocarditis vegetations were removed via a percutaneous approach using the AngioVac suction device. The device was modified by the surgeon, who sutured 2 threads to the head of the device in order to allow adjustments to be made to the angle of suction by applying tension on the suture. Real-time visualization of the procedure was achieved via transesophageal echocardiography. This approach, utilizing the AngioVac device, is a feasible and effective treatment strategy for endocarditis vegetation removal in selected patients who would otherwise be unsuitable candidates for open heart surgery.

Sign in / Sign up

Export Citation Format

Share Document